SMT (Sahajanand Medical Technologies Pvt. Ltd.) India’s largest manufacturer of cardiovascular medical stents today announced the successful results of S flex UK Registry. The one-year outcome data of the study was presented at The British Cardiovascular Intervention Society (BCIS) 2018 held in London UK. The outcome clearly demonstrated the safety and clinical performance of Supraflex Sirolimus-Eluting Coronary Stent System thereby setting a new benchmark in Indian cardiovascular industry which is ready to compete with global players. Titled as Prospective Evaluation of the Supraflex Sirolimus-Eluting Coronary Stent System in a 'Real-World' Patient Population the S Flex UK Registry trial was conducted among 469